ArticleJACC. Case reports2025
Stent With Occluder in the Valve Commissure Technique for Transcatheter Mitral Valve Replacement.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMitral annular calcification (MAC) is progressive degenerative calcification of the mitral valve that frequently results in mitral stenosis, mitral regurgitation, or both. Off-label transcatheter mitral valve replacement is the most common treatment in high to prohibitive surgical risk patients. Large mitral annular dimensions with risk of valve migration or paravalvular leak (PVL) remain a challenge. CASE PRESENTATION: We describe a case of a prohibitive surgical risk patient with multiple comorbidities who presented with heart failure symptoms. A transesophageal echocardiogram confirmed severe mitral valve stenosis and regurgitation in the setting of severe MAC, whereas computed tomography angiography showed large annular dimensions. Given these dimensions, there was significant concern for valve migration or PVL. DISCUSSION: We describe for the first time using a covered stent with occluder in the valve commissure to reduce the mitral valve annular area and facilitate a successful transcatheter mitral valve-in-MAC procedure in patients with a large mitral valve annulus. TAKE-HOME MESSAGES: Transcatheter mitral valve replacement using a balloon expandable valve in a large mitral valve annulus could be challenging because of concern for valve migration, embolization, or PVL. A covered stent with an occluder in the native valve commissure could help reduce the mitral valve annular dimensions and provide an additional anchor point for the transcatheter valve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.